Effect of fluvastatin on the expression of myocardial MCP-1 in rats with heart failure after acute myocardial infarction
Qiutang Zeng
Abstract
Qiutang Zeng
Abstract
Objective:To investigate the effect of fluvastatin on the expression of monocyte chemotactic protein-1(MCP-1)mRNA of myocardial tissue in rats with heart failure after acute myocardial infarction(AMI)Method:Six hours after ligating left coronary artery,surviving AMI female SD rats were randomly assigned to:1.AMI control;2.fluvastatin;3.sham-operated group are selected randomly as non-infarction control.After 8 weeks of therapy,We assessed cardiac function,hemodynamics,ventricular remodeling parameters,MCP-1 mRNA in left ventricular(LV)non-infarcted area(NIA).Result:Compared with sham-operated group,LV end-diastolic dimension(LVEDD),LV end-diastolic volume(LVEDV),E-wave,E-wave deceleration,E/A ratio,LV end diastolic pressure(LVEDP),relative weight(LVRW),right ventricular relative weight(RVRW),collagen volume fraction(CVF)and MCP-1 mRNA in NIA were all significantly increased in AMI group(P0.01),while fractional shortening(FS)and ejection fraction(EF)were all significantly decreased(P0.01).In comparison with AMI group,LVEDD,LVEDV,E-wave,E-wave deceleration,E/A,LVEDP,LVRW,RVRW,CVF and MCP-1 mRNA were all significantly decreased(P0.01),while FS and EF were all significantly increased in fluvastatin group(P0.01).Conclusion:Fluvastatin can attenuate LV remodeling and heart failure after AMI in the rat,Partly through down-regulating the expression of MCP-1 mRNA and improving inflammatory response.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effect of fluvastatin on the expression of monocyte chemotactic protein-1(MCP-1)mRNA of myocardial tissue in rats with heart failure after acute myocardial infarction(AMI)Method:Six hours after ligating left coronary artery,surviving AMI female SD rats were randomly assigned to:1.AMI control;2.fluvastatin;3.sham-operated group are selected randomly as non-infarction control.After 8 weeks of therapy,We assessed cardiac function,hemodynamics,ventricular remodeling parameters,MCP-1 mRNA in left ventricular(LV)non-infarcted area(NIA).Result:Compared with sham-operated group,LV end-diastolic dimension(LVEDD),LV end-diastolic volume(LVEDV),E-wave,E-wave deceleration,E/A ratio,LV end diastolic pressure(LVEDP),relative weight(LVRW),right ventricular relative weight(RVRW),collagen volume fraction(CVF)and MCP-1 mRNA in NIA were all significantly increased in AMI group(P0.01),while fractional shortening(FS)and ejection fraction(EF)were all significantly decreased(P0.01).In comparison with AMI group,LVEDD,LVEDV,E-wave,E-wave deceleration,E/A,LVEDP,LVRW,RVRW,CVF and MCP-1 mRNA were all significantly decreased(P0.01),while FS and EF were all significantly increased in fluvastatin group(P0.01).Conclusion:Fluvastatin can attenuate LV remodeling and heart failure after AMI in the rat,Partly through down-regulating the expression of MCP-1 mRNA and improving inflammatory response.
Key concepts: Medicine, Preload, Fluvastatin, Cardiology, Internal medicine, Myocardial infarction, Ejection fraction, Heart failure